| http://dbpedia.org/ontology/abstract
|
Eluxadoline, sold under the brand names Vi … Eluxadoline, sold under the brand names Viberzi and Truberzi, is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D). It was approved for use in the United States in 2015. The drug originated from Janssen Pharmaceutica and was developed by Actavis.harmaceutica and was developed by Actavis.
|
| http://dbpedia.org/ontology/alternativeName
|
Viberzi, Truberzi
|
| http://dbpedia.org/ontology/casNumber
|
864821-90-9
|
| http://dbpedia.org/ontology/fdaUniiCode
|
45TPJ4MBQ1
|
| http://dbpedia.org/ontology/kegg
|
D10403
|
| http://dbpedia.org/ontology/pubchem
|
11250029
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Eluxadoline.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
46829735
|
| http://dbpedia.org/ontology/wikiPageLength
|
11739
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1111956656
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Gallbladder +
, http://dbpedia.org/resource/Anticholinergic +
, http://dbpedia.org/resource/Category:Imidazoles +
, http://dbpedia.org/resource/Sphincter_of_Oddi +
, http://dbpedia.org/resource/Rhabdomyolysis +
, http://dbpedia.org/resource/Cytochrome_P450 +
, http://dbpedia.org/resource/Category:Mu-opioid_receptor_agonists +
, http://dbpedia.org/resource/Category:Kappa-opioid_receptor_agonists +
, http://dbpedia.org/resource/%CE%94-opioid_receptor +
, http://dbpedia.org/resource/Irritable_bowel_syndrome +
, http://dbpedia.org/resource/Enteric_nervous_system +
, http://dbpedia.org/resource/SLCO1B3 +
, http://dbpedia.org/resource/Alosetron +
, http://dbpedia.org/resource/Category:Diarrhea +
, http://dbpedia.org/resource/Agonist +
, http://dbpedia.org/resource/POU2F1 +
, http://dbpedia.org/resource/Gall_bladder +
, http://dbpedia.org/resource/Pancreatitis +
, http://dbpedia.org/resource/Opioids +
, http://dbpedia.org/resource/SLC22A8 +
, http://dbpedia.org/resource/Janssen_Pharmaceutica +
, http://dbpedia.org/resource/Drug +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Central_nervous_system +
, http://dbpedia.org/resource/SLCO1B1 +
, http://dbpedia.org/resource/Category:Antidiarrhoeals +
, http://dbpedia.org/resource/Organic_anion_transporter_1 +
, http://dbpedia.org/resource/ABCB11 +
, http://dbpedia.org/resource/Difenoxin +
, http://dbpedia.org/resource/OATP1B1 +
, http://dbpedia.org/resource/Rosuvastatin +
, http://dbpedia.org/resource/Diphenoxylate +
, http://dbpedia.org/resource/Category:Janssen_Pharmaceutica +
, http://dbpedia.org/resource/Asimadoline +
, http://dbpedia.org/resource/ABCG2 +
, http://dbpedia.org/resource/%CE%9C-opioid_receptor +
, http://dbpedia.org/resource/Category:Amines +
, http://dbpedia.org/resource/Bismuth_subsalicylate +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Loperamide +
, http://dbpedia.org/resource/Cyclosporine +
, http://dbpedia.org/resource/Category:Delta-opioid_receptor_antagonists +
, http://dbpedia.org/resource/Antiretroviral +
, http://dbpedia.org/resource/Actavis +
, http://dbpedia.org/resource/P-glycoprotein +
, http://dbpedia.org/resource/Area_under_the_curve_%28pharmacokinetics%29 +
, http://dbpedia.org/resource/Receptor_antagonist +
, http://dbpedia.org/resource/Axelopran +
, http://dbpedia.org/resource/Category:Carbamates +
, http://dbpedia.org/resource/Eltrombopag +
, http://dbpedia.org/resource/Rifampin +
, http://dbpedia.org/resource/%CE%9A-opioid_receptor +
, http://dbpedia.org/resource/Category:AbbVie_brands +
, http://dbpedia.org/resource/Abdominal_pain +
, http://dbpedia.org/resource/Category:Peripherally_selective_drugs +
, http://dbpedia.org/resource/Diarrhea +
, http://dbpedia.org/resource/Multidrug_resistance-associated_protein_2 +
, http://dbpedia.org/resource/Cmax_%28pharmacology%29 +
, http://dbpedia.org/resource/Gemfibrozil +
|
| http://dbpedia.org/property/atcPrefix
|
A07
|
| http://dbpedia.org/property/atcSuffix
|
DA06
|
| http://dbpedia.org/property/c
|
32
|
| http://dbpedia.org/property/casNumber
|
864821
|
| http://dbpedia.org/property/chemspiderid
|
9425062
|
| http://dbpedia.org/property/eliminationHalfLife
|
-21600.0
|
| http://dbpedia.org/property/excretion
|
82.2
|
| http://dbpedia.org/property/h
|
35
|
| http://dbpedia.org/property/image
|
Eluxadoline ball-and-stick model.png
|
| http://dbpedia.org/property/iupacName
|
5
|
| http://dbpedia.org/property/iupharLigand
|
7691
|
| http://dbpedia.org/property/kegg
|
D10403
|
| http://dbpedia.org/property/legalUs
|
Schedule IV
|
| http://dbpedia.org/property/licenceEu
|
yes
|
| http://dbpedia.org/property/n
|
5
|
| http://dbpedia.org/property/o
|
5
|
| http://dbpedia.org/property/pronounce
|
Viberzi
|
| http://dbpedia.org/property/proteinBound
|
81.0
|
| http://dbpedia.org/property/pubchem
|
11250029
|
| http://dbpedia.org/property/routesOfAdministration
|
By mouth
|
| http://dbpedia.org/property/smiles
|
CC1=CCCN
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
QFNHIDANIVGXPE-FNZWTVRRSA-N
|
| http://dbpedia.org/property/synonyms
|
JNJ-27018966
|
| http://dbpedia.org/property/tradename
|
Viberzi, Truberzi
|
| http://dbpedia.org/property/unii
|
45
|
| http://dbpedia.org/property/width
|
255
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Antidiarrheals%2C_intestinal_anti-inflammatory/anti-infective_agents +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Drugs_for_functional_gastrointestinal_disorders +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Irritable_bowel_syndrome +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:More_citations_needed +
, http://dbpedia.org/resource/Template:Opioidergics +
, http://dbpedia.org/resource/Template:Respell +
, http://dbpedia.org/resource/Template:IPAc-en +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Imidazoles +
, http://dbpedia.org/resource/Category:Peripherally_selective_drugs +
, http://dbpedia.org/resource/Category:AbbVie_brands +
, http://dbpedia.org/resource/Category:Janssen_Pharmaceutica +
, http://dbpedia.org/resource/Category:Antidiarrhoeals +
, http://dbpedia.org/resource/Category:Kappa-opioid_receptor_agonists +
, http://dbpedia.org/resource/Category:Delta-opioid_receptor_antagonists +
, http://dbpedia.org/resource/Category:Mu-opioid_receptor_agonists +
, http://dbpedia.org/resource/Category:Carbamates +
, http://dbpedia.org/resource/Category:Diarrhea +
, http://dbpedia.org/resource/Category:Amines +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Novel +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Eluxadoline?oldid=1111956656&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Eluxadoline.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Eluxadoline_ball-and-stick_model.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Eluxadoline +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q20539232 +
, http://rdf.freebase.com/ns/m.013b075v +
, http://yago-knowledge.org/resource/Eluxadoline +
, http://fa.dbpedia.org/resource/%D8%A7%DB%8C%D9%84%D9%88%DA%A9%D8%B3%D8%A7%D8%AF%D9%88%D9%84%DB%8C%D9%86 +
, http://dbpedia.org/resource/Eluxadoline +
, http://vi.dbpedia.org/resource/Eluxadoline +
, https://global.dbpedia.org/id/xM1m +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/Book +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Eluxadoline, sold under the brand names Vi … Eluxadoline, sold under the brand names Viberzi and Truberzi, is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D). It was approved for use in the United States in 2015. The drug originated from Janssen Pharmaceutica and was developed by Actavis.harmaceutica and was developed by Actavis.
|
| rdfs:label |
Eluxadoline
|
